Pharmaceutical Business Review
Return to: PBR Home
Search Results:
1-15 of 56101 results
APEJ to dominate the global plastic recycling market over the forecast period from 2017 to 2025: Persistence Market Research
A plastic recycling is a method of recouping waste or scrap plastic as well as reprocessing the material into valuable items. As most of the plastic is non-biodegradable, reusing is a part of worldwide attempt to decrease plastic waste.
Press Releases
Wound Cleanser Products Market : Augmented Tendency towards Online Shopping to Bolster Market Growth: Persistence Market Research
Wound cleanser products refer to solutions which are used in the removal of exudates, bacteria, foreign particles, and contaminants from the surface of a wound to facilitate fastest and healthiest healing environment.
Press Releases
ImmuPharma completes phase 3 trial of Lupus drug
ImmuPharma has completed its 52-week, randomised, double-blinded, phase 3 clinical trial of Lupuzor, its lead candidate for the potential breakthrough compound for Lupus.
Contract Research & Services > Clinical Trials > News
Almac to further expand Ireland campus with £30m investment
By PBR Staff Writer
Northern Ireland-based pharmaceutical firm Almac is investing £30m to further expand its European campus in Dundalk, Ireland to cope up with its existing and future client requirements in the European Union market.
Production & Manufacturing > Manufacturing > News
CGT Catapult enters into viral vector manufacturing technology collaboration with Freeline Therapeutics
The Cell and Gene Therapy Catapult (CGT Catapult) has partnered with Freeline Therapeutics to further develop the company’s proprietary manufacturing platform at the CGT Catapult’s large scale GMP manufacturing centre in Stevenage, Hertfordshire, UK.
USPTO invalidates J&J’s patent on prostate cancer drug Zytiga
By PBR Staff Writer
The US Patent & Trademark Office (USPTO) has invalidated a Johnson & Johnson (J&J) patent on prostate cancer drug Zytiga (abiraterone acetate).
Regulatory Affairs > News
X-Chem, AstraZeneca expand drug discovery partnership
X-Chem, a small molecule discovery specialist, has expanded its existing global drug discovery and technology transfer collaboration with AstraZeneca.
Drug Research > Drug Discovery & Development > News
Carmot Therapeutics secures funding for type 2 diabetes drug
Carmot Therapeutics, a biotechnology company, has closed a $15m financing to support the development of its type 2 diabetes drug, a dual GLP-1R/GIPR agonist, through early clinical proof of concept.
Drug Research > Drug Discovery & Development > News
Novartis’ Kymriah nabs speedy reviews in US, Europe for lymphoma treatment
By PBR Staff Writer
Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) has been granted fast-tracked reviews in the US and Europe for the treatment of relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL).
Regulatory Affairs > News
Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA
Sandoz, a Novartis division, announced that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA), submitted under the 351 (k) pathway, for proposed biosimilar adalimumab to the reference medicine, Humira.
Shire’s haemophilia A drug Adynovi secures approval in Europe
The European Commission (EC) has granted marketing authorization for Shire’s Adynovi [Antihemophilic Factor (Recombinant), PEGylated], an extended half-life recombinant factor VIII (rFVIII) treatment, for on-demand and prophylactic use in patients 12 years and older living with hemophilia A.
Regulatory Affairs > News
Merck’s Keytruda regimen succeeds in phase 3 NSCLC trial
By PBR Staff Writer
Merck’s Keytruda (pembrolizumab) in combination with pemetrexed (Alimta) plus platinum chemotherapy has significantly improved overall survival (OS) and progression-free survival (PFS) of certain type of lung cancer patients in a phase 3 trial.
Contract Research & Services > Clinical Trials > News
Midatech gets FDA IND approval to begin trial of brain cancer treatment
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved Midatech Pharma’s investigational new drug (IND) application to carry out a study of an investigational nano-inclusion product, MTX110, to treat fatal childhood brain cancer DIPG.
Regulatory Affairs > News
Mundipharma agrees to distribute Grünenthal's pain-relief drug in China
Mundipharma has agreed to market and distribute Grünenthal’s Tramal (tramadol) in China from 1 May 2018.
Drug Research > Drug Delivery > News
e-Therapeutics signs two collaboration deals to enhance AI technology capabilities
By PBR Staff Writer
UK-based drug developer e-Therapeutics has agreed to collaborate with Intellegens and Biorelate to improve and extend its artificial intelligence (AI) technology capabilities.
Drug Research > Drug Delivery > News

PBR Supplier Recommendations

Persistence Market Research: Next-Gen Industry Insights & Growth Outlook
Persistence Market Research (PMR) is essentially a third-party research firm. Our model of research is a remarkable coordinated effort of information investigation and market look into procedure to enable organizations to accomplish ideal execution. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.... Suppliers
Future Market Insights: Global Industry Outlook & Business Review
FMI, catering to clients in more than 150 different countries, is a top-ranking provider of market intelligence and research. We are headquartered in the global financial capital, London and boast of some of the finest delivery centers in the U.S. and India. Our research and consulting experts have helped a multitude of businesses to manage their individual challenges in an aggressively evolving marketplace with great precision and boldness.... Suppliers
Transparency Market Research: In-depth Analysis, Accurate Results
Transparency Market Research (TMR) is a pioneer enterprise in the field of market research. We provide a plethora of services ranging from customized research, syndicated research, and consultation services. TMR’s worldwide and regional insights on the market cover industries such as chemicals, pharmaceuticals, media and technology, consumer goods, food and beverages, among others. Every deeply researched report from TMR offers its clients a panoramic vision of the market, its prognosis and statistical forecasts, a detailed segmentation, key ongoing trends, vendor landscape along with strategic recommendations.... Suppliers
Lohmann Therapy System (LTS) - Transdermal Therapeutic Systems and Oral Thin Films
LTS is the market leader in alternative drug delivery systems, in the form of transdermal therapeutic systems and oral thin films. We develop and manufacture drug delivery systems that offer patients reliable therapeutic efficacy with total comfort and convenience.... Drug Research > Drug Delivery > Suppliers
Malvern Panalytical
Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. ... Suppliers
See more

PBR White Paper Recommendations

Malvern: Understanding and minimizing polycaprolactone degradation during processing using multi-detector GPC and rheology By Malvern Panalytical
Measuring degradation related changes in molecular weight and rheology during polycaprolactone processing... White Papers How Malvern Panalytical helped GSK India optimize their manufacturing process using By Malvern Panalytical
GSK India is headquartered at Worli, Mumbai with the manufacturing unit being located at Nashik. A second manufacturing facility at Vemgal, Karnataka is due to be completed in 2018.... White Papers Malvern: High sensitivity gel permeation chromatography for agrochemical analysis By Malvern Panalytical
Exploring why Syngenta opted for an OMNISEC system... White Papers Malvern: Measuring the rheology of thermoplastic polymer melts By Malvern Panalytical
Using rotational and capillary rheometry to characterize polymer melts... White Papers Malvern: Optimizing metal powders for additive manufacturing By Malvern Panalytical
Exploring the impact of particle morphology and powder flowability.... White Papers See more
1-15 of 56101 results